InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-27.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Nova Tina Susan, Présidente. Insider active across 3 companies, notably Arena Pharmaceuticals INC. Aggregated, 8 disclosures have been logged. History available since 11 June 2021. The latest transaction was filed on 7 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
4,040 shares@ US$52.3257.5% of flowCommonSEC:0000950170-25-017893:0
2,465 shares@ US$65.9342.5% of flowCommonSEC:0000950170-24-014558:0
3,604 shares0Common StockSEC:0001209191-23-009725:0
17,776 sharesCommon StockSEC:0001628280-22-005918:0
56,546 shares0Common StockSEC:0001384101-22-000052:0
10,695 shares@ US$27.840.0087% mcap100.0% of flowCommon StockSEC:0001384101-22-000038:0
3,067 shares0Common StockSEC:0001628280-21-012279
3,067 shares0Common StockSEC:0001628280-21-012279:0
8 of 8 declarations
About Nova Tina Susan
Tina Susan Nova is the President and CLIA U.S. Operations Director at ARENA PHARMACEUTICALS INC and VERACYTE, INC. She oversees the operational and strategic activities of both companies, bringing her expertise in the life sciences field. Her role is essential in ensuring regulatory compliance and innovation in product development. Through her leadership, she contributes to the growth and success of the organizations.
